Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively affect U.S. patients, here are some of the latest resources to keep in your back pocket:
- What is the truth about importation? Learn the facts in our Myths vs. Facts graphic.
- Many are concerned about the safety of drugs imported from other countries –our pocket card explains how importation schemes could harm patients.
- Ordering medicine through an online Canadian pharmacy may not be what you think. To better understand the realities of drug importation from Canada, check out our graphic and read our case study on the danger of online pharmacies.
- Another danger of large-scale importation proposals is an increased risk of counterfeit medicines entering the United States. Take a look at these cases of counterfeit cancer drugs entering the United States and counterfeit hepatitis C drugs found in Switzerland.
- Importation schemes won’t just endanger patients – read more about how they would increase the burden on U.S. law enforcement.
- And learn what others are saying – including former commissioners of the U.S. Food and Drug Administration – about these proposals.
You can get information on drug importation and more delivered to your inbox by subscribing to the Catalyst. Stay up to date on drug importation at PhRMA.org/Importation.
Nicole Longo
Nicole Longo is Deputy Vice President of public affairs at PhRMA focusing on Medicare, 340B, importation and more. She previously worked for a D.C.-based public affairs firm where she assisted a wide range of clients with communications efforts on everything from trade policy to agriculture policy to health care policy. Outside the office, Nicole can be found trying new restaurants (usually Italian), taking an occasional barre class and cheering on the Cincinnati Bengals.
Nicole Longo
More oversight needed of unapproved medicines that threaten patients’ health
What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous
Florida’s importation plan puts patients in danger
Three things to know about the accelerated approval pathway
ICYMI: Antimicrobial resistance spotlighted as growing public health threat
Why drug importation is bad for Americans
PhRMA submits comments on FDA’s proposed rule on drug importation
Drug importation: An old idea that is still a bad idea
What they’re saying: Safety is top concern for recent drug importation proposal
ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals
PhRMA responds to Florida’s request for information on drug importation
PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients
Look at the facts. Drug importation is dangerous.
Securely dispose of your unwanted medicines on National Take Back Day
The Washington Post retracts PhRMA claim in opioid story
PhRMA response to Washington Post and 60 Minutes stories
VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria
Protect your health: Important disaster preparedness tips for Harvey and Irma
PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis
Opportunities to build upon enhanced competition for medicines in the marketplace
A critical opportunity to prevent prescription drug abuse
Former law enforcement officials raise concerns with drug importation proposals
How drug importation schemes could increase U.S. law enforcement burdens
Case Study: How one online pharmacy knowingly endangered U.S. consumers
Why drug importation threatens patient safety
Fact Check Friday: The truth about drug importation and patient safety
What you don’t know about importation from Canada
Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients
Resources for understanding the dangers of drug importation
Prescription Drug Safety
Drug Importation
Resources for understanding the dangers of drug importation
Resources for understanding the dangers of drug importation